These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 870569
1. Severe generalized glutathione reductase deficiency after antitumor chemotherapy with BCNU" [1,3-bis(chloroethyl)-1-nitrosourea]. Frischer H, Ahmad T. J Lab Clin Med; 1977 May; 89(5):1080-91. PubMed ID: 870569 [Abstract] [Full Text] [Related]
2. Consequences of erythrocytic glutathione reductase deficiency. Frischer H, Ahmad T. J Lab Clin Med; 1987 May; 109(5):583-8. PubMed ID: 3572207 [Abstract] [Full Text] [Related]
9. Mechanism of inhibition of red blood cell glutathione reductase activity by BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea). Shinohara K, Tanaka KR. Clin Chim Acta; 1979 Mar 01; 92(2):147-52. PubMed ID: 39688 [Abstract] [Full Text] [Related]
10. The effects of BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea) on glutathione reductase and other enzymes in mouse tissue. Maker HS, Weiss C, Brannan TS. Res Commun Chem Pathol Pharmacol; 1983 Jun 01; 40(3):355-66. PubMed ID: 6622814 [Abstract] [Full Text] [Related]
11. Increased oxidative stress created by adenoviral MnSOD or CuZnSOD plus BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) inhibits breast cancer cell growth. Weydert CJ, Zhang Y, Sun W, Waugh TA, Teoh ML, Andringa KK, Aykin-Burns N, Spitz DR, Smith BJ, Oberley LW. Free Radic Biol Med; 2008 Mar 01; 44(5):856-67. PubMed ID: 18155673 [Abstract] [Full Text] [Related]
13. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cohen MB, Duvel DL. Biochem Pharmacol; 1988 Sep 01; 37(17):3317-20. PubMed ID: 3401259 [Abstract] [Full Text] [Related]
14. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU. Rice KP, Penketh PG, Shyam K, Sartorelli AC. Biochem Pharmacol; 2005 May 15; 69(10):1463-72. PubMed ID: 15857610 [Abstract] [Full Text] [Related]
15. Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs. Hohl RJ, Kennedy EJ, Frischer H. J Lab Clin Med; 1991 Apr 15; 117(4):325-31. PubMed ID: 1901343 [Abstract] [Full Text] [Related]
16. A role for glutathione and glutathione reductase in control of corneal hydration. Riley MV. Exp Eye Res; 1984 Dec 15; 39(6):751-8. PubMed ID: 6519203 [Abstract] [Full Text] [Related]
17. Enhanced oxygen toxicity following treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea. Kehrer JP, Paraidathathu T. Fundam Appl Toxicol; 1984 Oct 15; 4(5):760-7. PubMed ID: 6510607 [Abstract] [Full Text] [Related]
18. The effect of BCNU (carmustine) on tissue glutathione reductase activity. Kehrer JP. Toxicol Lett; 1983 Jun 15; 17(1-2):63-8. PubMed ID: 6623510 [Abstract] [Full Text] [Related]
19. Inhibition of human glutathione reductase by the nitrosourea drugs 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(2-hydroxyethyl)-1-nitrosourea. A crystallographic analysis. Karplus PA, Krauth-Siegel RL, Schirmer RH, Schulz GE. Eur J Biochem; 1988 Jan 15; 171(1-2):193-8. PubMed ID: 3338461 [Abstract] [Full Text] [Related]
20. Reduction of glutathione levels in livers of mice treated with N,N'-bis (2-chloroethyl)-N-nitrosourea. McConnell WR, Kari P, Hill DL. Cancer Chemother Pharmacol; 1979 Jan 15; 2(3):221-3. PubMed ID: 455578 [Abstract] [Full Text] [Related] Page: [Next] [New Search]